Compare Aurobindo Pharma with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA PROCTER & GAMBLE HEALTH AUROBINDO PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 9.9 47.8 20.7% View Chart
P/BV x 3.2 10.1 31.2% View Chart
Dividend Yield % 0.3 4.2 7.9%  

Financials

 AUROBINDO PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-20
PROCTER & GAMBLE HEALTH
Jun-20
AUROBINDO PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs8385,121 16.4%   
Low Rs2812,928 9.6%   
Sales per share (Unadj.) Rs394.2816.8 48.3%  
Earnings per share (Unadj.) Rs48.5153.1 31.7%  
Cash flow per share (Unadj.) Rs65.0170.8 38.1%  
Dividends per share (Unadj.) Rs3.00230.00 1.3%  
Dividend yield (eoy) %0.55.7 9.4%  
Book value per share (Unadj.) Rs286.9544.8 52.7%  
Shares outstanding (eoy) m585.9316.60 3,529.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.44.9 28.8%   
Avg P/E ratio x11.526.3 43.8%  
P/CF ratio (eoy) x8.623.6 36.5%  
Price / Book Value ratio x2.07.4 26.4%  
Dividend payout %6.2150.3 4.1%   
Avg Mkt Cap Rs m327,87266,801 490.8%   
No. of employees `000NANA-   
Total wages/salary Rs m32,1921,829 1,759.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m230,98513,559 1,703.6%  
Other income Rs m1,919700 274.3%   
Total revenues Rs m232,90414,258 1,633.5%   
Gross profit Rs m48,3823,143 1,539.2%  
Depreciation Rs m9,667295 3,282.5%   
Interest Rs m3,0510-   
Profit before tax Rs m37,5823,549 1,059.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,1351,008 906.5%   
Profit after tax Rs m28,4472,541 1,119.6%  
Gross profit margin %20.923.2 90.3%  
Effective tax rate %24.328.4 85.6%   
Net profit margin %12.318.7 65.7%  
BALANCE SHEET DATA
Current assets Rs m164,12512,675 1,294.9%   
Current liabilities Rs m113,8685,386 2,114.1%   
Net working cap to sales %21.853.8 40.5%  
Current ratio x1.42.4 61.3%  
Inventory Days Days15195 7.8%  
Debtors Days Days6826 265.9%  
Net fixed assets Rs m123,5078,447 1,462.2%   
Share capital Rs m586166 353.0%   
"Free" reserves Rs m167,5188,878 1,886.9%   
Net worth Rs m168,1049,044 1,858.7%   
Long term debt Rs m00-   
Total assets Rs m287,63221,121 1,361.8%  
Interest coverage x13.3NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 125.1%   
Return on assets %11.012.0 91.0%  
Return on equity %16.928.1 60.2%  
Return on capital %24.239.2 61.6%  
Exports to sales %46.40-   
Imports to sales %15.116.9 89.5%   
Exports (fob) Rs m107,126NA-   
Imports (cif) Rs m34,9022,290 1,524.3%   
Fx inflow Rs m107,4452,175 4,940.0%   
Fx outflow Rs m38,9912,290 1,702.9%   
Net fx Rs m68,454-115 -59,680.6%   
CASH FLOW
From Operations Rs m43,8132,354 1,861.4%  
From Investments Rs m-15,6761,646 -952.2%  
From Financial Activity Rs m-19,472-8,834 220.4%  
Net Cashflow Rs m8,712-4,834 -180.2%  

Share Holding

Indian Promoters % 48.8 0.0 -  
Foreign collaborators % 3.1 51.8 5.9%  
Indian inst/Mut Fund % 38.4 18.3 210.1%  
FIIs % 23.7 6.5 367.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 48.2 100.0%  
Shareholders   243,315 58,818 413.7%  
Pledged promoter(s) holding % 22.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   ERIS LIFESCIENCES  COMBAT DRUGS  ADESHWAR MEDITEX  SOURCE NATURAL FOODS  CIPLA  



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

These Stocks Are Ready to Zoom(Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider(Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks(Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Aug 5, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS